previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00843 | 1 | SACOL1859 | 57284780 | hypothetical protein SACOL1859 | 1016 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00589 | 1 | YPO0954 | 161486886 | mltC | membrane-bound lytic murein transglycosy... | 358 | Drug Target Function | March 2008 | 1QSA | 17.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01401 | 1 | VC0773 | 15640792 | vibriobactin-specific isochorismate synt... | 395 | Drug Target Function | March 2008 | 2EUA | 24.6% | Vibrio cholerae | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP00494 | 1 | YPO0099 | 16120446 | hypothetical protein YPO0099 | 411 | Drug Target Function | March 2008 | Yersinia pestis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP00736 | 1 | SACOL0966 | 57285840 | pgi | glucose-6-phosphate isomerase | 443 | Drug Target Function | March 2008 | 1B0Z | 63.2% | Staphylococcus aureus | Energy metabolism | Glycolysis/gluconeogenesis | |||||||||||||||||
| IDP00346 | 1 | lmo0489 | 16802532 | hypothetical protein lmo0489 | 664 | Drug Target Function | March 2008 | 1DJN | 27.9% | Listeria monocytogenes | Energy metabolism | Electron transport | ||||||||||||||||||
| IDP00355 | 1 | lmo2526 | 16804564 | murA | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 430 | Drug Target Function | March 2008 | 2RL1 | 49.1% | Listeria monocytogenes | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00805 | 1 | SACOL1801 | 57286235 | dipeptidase PepV | 469 | Drug Target Function | March 2008 | 1LFW | 35.2% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01438 | 1 | VC1993 | 15641995 | 2,4-dienoyl-CoA reductase | 666 | Drug Target Function | March 2008 | 1PS9 | 57.1% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Degradation | ||||||||||||||||||
| IDP01176 | 1 | BA_2869 | 30257466 | peptidase, putative | 358 | Drug Target Function | March 2008 | 3CE2 | 22.9% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00685 | 1 | SACOL2016 | 57284887 | groEL | chaperonin GroEL | 538 | Drug Target Function | March 2008 | 1IOK | 59.7% | Staphylococcus aureus | Protein fate | Protein folding and stabilization | |||||||||||||||||
| IDP01225 | 1 | BA_4139 | 61211625 | Phosphopantetheine adenylyltransferase (... | 163 | Drug Target Function | March 2008 | 1O6B | 71.2% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Pantothenate and coenzyme A | ||||||||||||||||||
| IDP01512 | 1 | VC1173 | 15641186 | anthranilate synthase component II | 203 | Drug Target Function | March 2008 | 1I1Q | 57.1% | Vibrio cholerae | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP00714 | 1 | SACOL1198 | 57285941 | ftsA | cell division protein FtsA | 470 | Drug Target Function | March 2008 | 1E4F | 18.3% | Staphylococcus aureus | Cellular processes | Cell division | |||||||||||||||||
| IDP00692 | 1 | SACOL2128 | 57286344 | pdp | pyrimidine-nucleoside phosphorylase | 433 | Drug Target Function | March 2008 | 1BRW | 68.4% | Staphylococcus aureus | Purines, pyrimidines, nucleosides, and nucleotides | Other | |||||||||||||||||
| IDP01218 | 1 | BA_3712 | 73919984 | Histidine ammonia-lyase (Histidase) | 505 | Drug Target Function | March 2008 | 1B8F | 42.2% | Bacillus anthracis | Energy metabolism | Amino acids and amines | ||||||||||||||||||
| IDP01226 | 1 | BA_4187 | 39931064 | Peptide deformylase 2 (PDF 2) (Polypepti... | 184 | Drug Target Function | March 2008 | 2OKL | 96.2% | Bacillus anthracis | Protein fate | Protein modification and repair | ||||||||||||||||||
| IDP00734 | 1 | SACOL0841 | 57284303 | pgm | phosphoglyceromutase | 505 | Drug Target Function | March 2008 | 1EJJ | 62.6% | Staphylococcus aureus | Energy metabolism | Glycolysis/gluconeogenesis | |||||||||||||||||
| IDP01487 | 1 | VCA0270 | 15601038 | D-alanyl-D-alanine carboxypeptidase | 389 | Drug Target Function | March 2008 | 1NZO | 44.5% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00742 | 1 | SACOL1276 | 57286013 | tsf | elongation factor Ts | 293 | Drug Target Function | March 2008 | 1EFU | 43.7% | Staphylococcus aureus | Protein synthesis | Translation factors | |||||||||||||||||
| IDP00759 | 1 | SACOL0188 | 57285390 | ggt | gamma-glutamyltranspeptidase | 668 | Drug Target Function | March 2008 | 2E0W | 27.8% | Staphylococcus aureus | Biosynthesis of cofactors, prosthetic groups, and carriers | Glutathione and analogs | |||||||||||||||||
| IDP00809 | 1 | SACOL1869 | 57284790 | splA | serine protease SplA | 238 | Drug Target Function | March 2008 | 2AS9 | 44.1% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP01059 | 1 | STM3509 | 16766797 | bioH | carboxylesterase BioH | 256 | Drug Target Function | March 2008 | 1M33 | 79.3% | Salmonella typhimurium | Biosynthesis of cofactors, prosthetic groups, and carriers | Biotin | |||||||||||||||||
| IDP00329 | 1 | Cj1724c | 15793027 | 7-cyano-7-deazaguanine reductase | 127 | Drug Target Function | March 2008 | Campylobacter jejuni | Amino acid biosynthesis | Pyruvate family | ||||||||||||||||||||
| IDP00807 | 1 | SACOL1865 | 57284786 | serine protease SplE, putative | 238 | Drug Target Function | March 2008 | 2VID | 44.5% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01201 | 1 | BA_1826 | 34098434 | 3-oxoacyl-[acyl-carrier-protein] synthas... | 327 | Drug Target Function | March 2008 | 1ZOW | 40.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01230 | 1 | BA_4638 | 33300883 | Adenine phosphoribosyltransferase (APRT)... | 170 | Drug Target Function | March 2008 | 2DY0 | 52.4% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Salvage of nucleosides and nucleotides | ||||||||||||||||||
| IDP00674 | 1 | SACOL1453 | 57286104 | murG | N-acetylglucosaminyl transferase | 356 | Drug Target Function | March 2008 | 1F0K | 25.6% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00308 | 1 | CBU_0288 | 29653640 | coaD | phosphopantetheine adenylyltransferase | 159 | Drug Target Function | March 2008 | 1OD6 | 47.2% | Coxiella burnetii | Biosynthesis of cofactors, prosthetic groups, and carriers | Pantothenate and coenzyme A | |||||||||||||||||
| IDP01382 | 1 | VC0533 | 15640555 | lipoprotein NlpD | 311 | Drug Target Function | March 2008 | 1QWY | 24.1% | Vibrio cholerae | Cell envelope | Other | ||||||||||||||||||
| IDP00637 | 1 | SACOL1727 | 57284738 | infC | translation initiation factor IF-3 | 175 | Drug Target Function | March 2008 | 1TIG | 37.7% | Staphylococcus aureus | Protein synthesis | Translation factors | |||||||||||||||||
| IDP00310 | 1 | CBU_0493 | 29653835 | fabH | 3-oxoacyl-(acyl-carrier-protein) synthas... | 319 | Drug Target Function | March 2008 | 1HN9 | 54.5% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00307 | 1 | CBU_0142 | 29653500 | lpxC | UDP-3-0-acyl N-acetylglucosamine deacety... | 303 | Drug Target Function | March 2008 | 2VES | 65.7% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00311 | 1 | CBU_0494 | 29653836 | fabD | malonyl CoA-acyl carrier protein transac... | 313 | Drug Target Function | March 2008 | 1MLA | 54% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00303 | 1 | CBU_0035 | 29653398 | beta-ketoacyl synthase | 424 | Drug Target Function | March 2008 | 3E60 | 37.3% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00319 | 1 | CBU_2070 | 29655348 | chorismate mutase, putative | 136 | Drug Target Function | March 2008 | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||||
| IDP00309 | 1 | CBU_0298 | 29653649 | murI | glutamate racemase | 280 | Drug Target Function | March 2008 | 2GZM | 38.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00306 | 1 | CBU_0137 | 29653495 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 316 | Drug Target Function | March 2008 | 1HSK | 34.5% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00315 | 1 | CBU_0874 | 29654200 | aroC | chorismate synthase | 352 | Drug Target Function | March 2008 | 1R52 | 46.6% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00316 | 1 | CBU_1152 | 29654458 | trpE | anthranilate synthase component I | 463 | Drug Target Function | March 2008 | 1QDL | 34.3% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00320 | 1 | CBU_0550 | 29653890 | pbpA | penicillin-binding protein 2 | 612 | Drug Target Function | March 2008 | 1MWR | 25.3% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01246 | 1 | BA_2648 | 30257265 | penicillin-binding protein | 712 | Drug Target Function | March 2008 | 1QME | 29.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00314 | 1 | CBU_0751 | 29654085 | murA | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 434 | Drug Target Function | March 2008 | 1EJC | 56.9% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00312 | 1 | CBU_0497 | 29653839 | fabF | 3-oxoacyl-acyl carrier protein synthase ... | 414 | Drug Target Function | March 2008 | 1B3N | 60.1% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01435 | 1 | VC1956 | 15641958 | lytic murein transglycosylase, putative ... | 323 | Drug Target Function | March 2008 | 1D0K | 28.2% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00302 | 1 | CBU_1155 | 29654460 | trpBF | N-(5'phosphoribosyl)anthranilate isomera... | 600 | Drug Target Function | March 2008 | 1V8Z | 38% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00317 | 1 | CBU_1887 | 29655172 | ponA | penicillin-binding protein 1A | 793 | Drug Target Function | March 2008 | 2OLU | 23.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00318 | 1 | CBU_1947 | 29655231 | glmU | UDP-N-acetylglucosamine pyrophosphorylas... | 455 | Drug Target Function | March 2008 | 1HV9 | 51.4% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00752 | 1 | SACOL2211 | 57284992 | ABC transporter, ATP-binding protein | 269 | Drug Target Function | March 2008 | 3DHW | 31.6% | Staphylococcus aureus | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP00596 | 1 | YPO0555 | 16120883 | murG | N-acetylglucosaminyl transferase | 356 | Drug Target Function | March 2008 | 1F0K | 78.4% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00304 | 1 | CBU_0038 | 29653401 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 327 | Drug Target Function | March 2008 | 1UB7 | 29.4% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01397 | 1 | VC0755 | 161582019 | aminopeptidase B | 429 | Drug Target Function | March 2008 | 1GYT | 29.8% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00305 | 1 | CBU_0118 | 29653476 | pbpB | penicillin-binding protein 3 | 548 | Drug Target Function | March 2008 | 3EQU | 39.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01051 | 1 | STM3219 | 16766518 | fadH | 2,4-dieonyl-CoA reductase | 672 | Drug Target Function | March 2008 | 1PS9 | 85.6% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Degradation | |||||||||||||||||
| IDP01412 | 1 | VC1122 | 15641135 | cyclopropane-fatty-acyl-phospholipid syn... | 432 | Drug Target Function | March 2008 | 1KPI | 18.7% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00313 | 1 | CBU_0647 | 29653985 | ribA | riboflavin biosynthesis protein RibA | 406 | Drug Target Function | March 2008 | 2BZ0 | 27.1% | Coxiella burnetii | Biosynthesis of cofactors, prosthetic groups, and carriers | Riboflavin, FMN, and FAD | |||||||||||||||||
| IDP01335 | 1 | VC1144 | 15641157 | clpA | ATP-dependent Clp protease ATP-binding s... | 756 | Drug Target Function | March 2008 | 1KSF | 77.9% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP01480 | 1 | VCA0116 | 15600887 | clpB protein | 869 | Drug Target Function | March 2008 | 1QVR | 36.4% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00607 | 1 | SACOL2116 | 57286332 | murAB | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 419 | Drug Target Function | March 2008 | 1NAW | 42% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01219 | 1 | BA_3767 | 30258283 | prophage LambdaBa01, N-acetylmuramoyl-L-... | 310 | Drug Target Function | March 2008 | 1YB0 | 39% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01495 | 1 | VCA0803 | 15601558 | serine protease, putative | 330 | Drug Target Function | March 2008 | 1BRU | 24.2% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01437 | 1 | VC1983 | 15641985 | peptidase, putative | 615 | Drug Target Function | March 2008 | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||||
| IDP01394 | 1 | VC0700 | 15640719 | soluble lytic murein transglycosylase | 648 | Drug Target Function | March 2008 | 1QSA | 33.8% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01428 | 1 | VC1709 | 15641713 | zinc protease, insulinase family | 922 | Drug Target Function | March 2008 | 3CWW | 19% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01224 | 1 | BA_4054 | 30258561 | sporulation specific penicillin-binding ... | 638 | Drug Target Function | March 2008 | 1PYY | 26.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01240 | 1 | BA_1069 | 30254800 | pbpF | penicillin-binding protein 1 | 705 | Drug Target Function | March 2008 | 2OLU | 27.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01449 | 1 | VC2248 | 15642246 | UDP-N-acetylglucosamine acyltransferase ... | 262 | Drug Target Function | March 2008 | 1LXA | 68.3% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00441 | 1 | YPO2207 | 16122435 | trpG | anthranilate synthase component II | 192 | Drug Target Function | March 2008 | 1I7Q | 87.5% | Yersinia pestis | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00986 | 1 | STM2106 | 16765436 | wcaI | predicted glycosyl transferase | 407 | Drug Target Function | March 2008 | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||||
| IDP00591 | 1 | YPO0145 | 161486893 | mrcA | penicillin-binding protein | 859 | Drug Target Function | March 2008 | 2JCH | 21% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01509 | 1 | VC0549 | 15640571 | oxaloacetate decarboxylase subunit gamma... | 117 | Drug Target Function | March 2008 | Vibrio cholerae | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||||
| IDP00898 | 1 | STM2114 | 16765444 | wcaB | putative colanic acid biosynthesis acety... | 162 | Drug Target Function | March 2008 | 1T3D | 29.6% | Salmonella typhimurium | Amino acid biosynthesis | Serine family | |||||||||||||||||
| IDP01376 | 1 | VC0400 | 15640427 | MSHA biogenesis protein MshJ | 216 | Drug Target Function | March 2008 | Vibrio cholerae | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00444 | 1 | YPO0342 | 16120677 | putative oxidoreductase Fe-S binding sub... | 671 | Drug Target Function | ||||||||||||||||||||||||